Nanjing Vazyme Biotech Co Ltd (688105) — Financial Flexibility Index
Nanjing Vazyme Biotech Co Ltd (688105) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥91.13 Million (operating CF CN¥75.30 Million minus capex CN¥15.83 Million) represents 0% of total liabilities (CN¥1.17 Billion). Also explore Nanjing Vazyme Biotech Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nanjing Vazyme Biotech Co Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Nanjing Vazyme Biotech Co Ltd across 9 annual periods. Check 688105 financial resilience to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Nanjing Vazyme Biotech Co Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for Nanjing Vazyme Biotech Co Ltd. For the full company profile including market capitalisation, see Nanjing Vazyme Biotech Co Ltd (688105) total market value.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | CN¥280.54 Million | CN¥233.16 Million | CN¥1.24 Billion | ▲ +284.4% |
| 2024 | 0.06x | CN¥65.21 Million | CN¥-9.68 Million | CN¥1.11 Billion | ▼ -76.5% |
| 2023 | 0.25x | CN¥431.31 Million | CN¥198.40 Million | CN¥1.72 Billion | ▼ -79.4% |
| 2022 | 1.22x | CN¥1.70 Billion | CN¥735.17 Million | CN¥1.39 Billion | ▼ -33.4% |
| 2021 | 1.83x | CN¥878.76 Million | CN¥616.80 Million | CN¥479.83 Million | ▼ -46.5% |
| 2020 | 3.42x | CN¥956.10 Million | CN¥803.55 Million | CN¥279.28 Million | ▲ +1113.1% |
| 2019 | 0.28x | CN¥35.08 Million | CN¥15.20 Million | CN¥124.31 Million | ▼ -15.1% |
| 2018 | 0.33x | CN¥28.13 Million | CN¥-4.00 Million | CN¥84.67 Million | ▼ -16.5% |
| 2017 | 0.40x | CN¥14.96 Million | CN¥-3.86 Million | CN¥37.57 Million | — |